Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.35 - $1.07 $135 - $414
387 Added 312.1%
511 $0
Q1 2024

Nov 05, 2024

SELL
$0.64 - $1.13 $247 - $437
-387 Reduced 75.73%
124 $0
Q1 2024

May 15, 2024

SELL
$0.64 - $1.13 $202 - $358
-317 Reduced 71.88%
124 $0
Q4 2023

Feb 14, 2024

SELL
$0.56 - $0.8 $360,702 - $515,289
-644,112 Reduced 99.93%
441 $0
Q3 2023

Nov 14, 2023

SELL
$0.71 - $1.06 $139,046 - $207,590
-195,840 Reduced 23.3%
644,553 $483,000
Q2 2023

Aug 14, 2023

BUY
$0.89 - $1.36 $708,153 - $1.08 Million
795,678 Added 1779.44%
840,393 $815,000
Q1 2023

May 15, 2023

BUY
$0.87 - $2.11 $38,886 - $94,310
44,697 Added 248316.67%
44,715 $38,000
Q4 2022

Feb 14, 2023

BUY
$0.89 - $28.0 $4 - $140
5 Added 38.46%
18 $0
Q2 2022

Aug 15, 2022

SELL
$1.04 - $2.14 $1,349 - $2,777
-1,298 Reduced 99.01%
13 $0
Q1 2022

May 16, 2022

SELL
$2.08 - $12.2 $6,346 - $37,222
-3,051 Reduced 69.94%
1,311 $3,000
Q4 2021

Feb 14, 2022

BUY
$11.48 - $17.69 $29,779 - $45,887
2,594 Added 146.72%
4,362 $52,000
Q3 2021

Nov 15, 2021

BUY
$14.57 - $17.72 $7,051 - $8,576
484 Added 37.69%
1,768 $27,000
Q2 2021

Aug 16, 2021

BUY
$20.3 - $33.6 $26,065 - $43,142
1,284 New
1,284 $26,000

Others Institutions Holding ALGS

About Aligos Therapeutics, Inc.


  • Ticker ALGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,717,000
  • Market Cap $751M
  • Description
  • Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...
More about ALGS
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.